A promising target for immunotherapy? – ModernMedicine
|
A promising target for immunotherapy?
ModernMedicine Rosalyn M. Adam, PhDAmong the AUA annual meeting take-home messages in basic science is that the immune co-stimulatory molecule B7-H4 is highly expressed in the luminal subtype of bladder urothelial carcinoma and is associated with poor survival. |
